BR0111193A - Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma. - Google Patents

Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma.

Info

Publication number
BR0111193A
BR0111193A BR0111193-0A BR0111193A BR0111193A BR 0111193 A BR0111193 A BR 0111193A BR 0111193 A BR0111193 A BR 0111193A BR 0111193 A BR0111193 A BR 0111193A
Authority
BR
Brazil
Prior art keywords
preparation process
amorphous form
sertraline hydrochloride
new amorphous
new
Prior art date
Application number
BR0111193-0A
Other languages
English (en)
Inventor
Brij Khera
Yatendra Kumar
Amit Rohatgi
Om Dutt Tyagi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BR0111193A publication Critical patent/BR0111193A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"NOVA FORMA AMORFA DE HIDROCLORETO DE SERTRALINA E PROCESSO DE PREPARAçãO DA MESMA". A presente invenção refere-se a uma nova forma amorfa do hidrocloreto de sertralina e a um processo para a preparação da mesma.
BR0111193-0A 2000-05-26 2001-05-24 Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma. BR0111193A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN540DE2000 IN192343B (pt) 2000-05-26 2000-05-26
PCT/IB2001/000909 WO2001090049A1 (en) 2000-05-26 2001-05-24 Novel amorphous form of sertraline hydrochloride

Publications (1)

Publication Number Publication Date
BR0111193A true BR0111193A (pt) 2003-07-29

Family

ID=11097055

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111193-0A BR0111193A (pt) 2000-05-26 2001-05-24 Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma.

Country Status (11)

Country Link
US (1) US20040063792A1 (pt)
EP (1) EP1289928A4 (pt)
JP (1) JP2003534310A (pt)
CN (1) CN1438989A (pt)
AU (1) AU2001256595A1 (pt)
BR (1) BR0111193A (pt)
CA (1) CA2409856A1 (pt)
CZ (1) CZ20023903A3 (pt)
IN (1) IN192343B (pt)
SK (1) SK17272002A3 (pt)
WO (1) WO2001090049A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
PT1248605E (pt) 1999-12-21 2007-03-30 Teva Pharma Novos polimorfos de cloridrato de sertralina, processos para a sua preparação, composições que os contêm e métodos para a sua utilização
CA2448279A1 (en) 2001-05-31 2002-12-05 Orion Corporation Fermion Process for preparing sertraline hydrochloride polymorphic form ii
WO2003093217A1 (en) 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
US7189876B2 (en) 2003-07-15 2007-03-13 Recordati Industria Chimica E Farmaceutica S.P.A. Methods for preparing sertraline hydrochloride polymorphs
EP1646605A1 (en) * 2003-07-15 2006-04-19 Recordati Industria Chimica e Farmaceutica S.p.A. Sertraline hydrochloride form ii and methods for the preparation thereof
EP1776049A2 (en) * 2005-01-27 2007-04-25 Teva Pharmaceutical Industries Ltd. Duloxetine hcl polymorphs
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
DE102008039271A1 (de) * 2007-12-23 2009-06-25 Euromed Sa Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
HUE048016T2 (hu) * 2011-01-21 2020-05-28 Avery Dennison Corp Klórhexidin-glükonátot tartalmazó ragasztó
WO2012158483A2 (en) 2011-05-16 2012-11-22 Avery Dennison Corporation Adhesive containing microparticles
BR112015019044B1 (pt) 2013-02-07 2022-02-08 Avery Dennison Corporation Composição adesiva antimicrobiana, seu artgo médico, e método de aumentar a liberação de um agente antimicrobiano a partir de uma composição adesiva
EP2968014B1 (en) 2013-03-15 2019-04-24 Avery Dennison Corporation Transparent cover dressing application system and inclusion of label strip
EP3789014A1 (en) 2014-06-05 2021-03-10 Avery Dennison Corporation Articles with active agent concentrated at the substrate contacting surface and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5166437A (en) * 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
JP2000026378A (ja) * 1998-07-03 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンの製法
WO2000032551A1 (en) * 1998-11-27 2000-06-08 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride

Also Published As

Publication number Publication date
WO2001090049A1 (en) 2001-11-29
AU2001256595A1 (en) 2001-12-03
IN192343B (pt) 2004-04-10
CN1438989A (zh) 2003-08-27
EP1289928A1 (en) 2003-03-12
CA2409856A1 (en) 2001-11-29
EP1289928A4 (en) 2005-06-08
JP2003534310A (ja) 2003-11-18
CZ20023903A3 (cs) 2003-05-14
US20040063792A1 (en) 2004-04-01
SK17272002A3 (sk) 2003-05-02

Similar Documents

Publication Publication Date Title
BR0111193A (pt) Nova forma amorfa de hidrocloreto de sertralina e processo de preparação da mesma.
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
BRPI0502382A (pt) processo para a preparação de artigos moldados de poliuretano
PT1303478E (pt) Processo para a preparacao de alcanoilamidas substituidas
BR0114316A (pt) Processo para a preparação de formulações em pó
BR0307529A (pt) Derivados de n-fenil-2-pirimidina-amina
BRPI0316438C1 (pt) uso de eritropoietina em doenças cardíacas
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
BRPI9814894A (pt) processo para a preparação de ácidos 8-metóxi-quinolonocarboxílicos.
BR0112018B1 (pt) processo para preparar uma composiÇço para o tratamento de tecido.
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
PT1272489E (pt) Processo para a preparacao da forma i cristalina de cabergolina
PT1345939E (pt) Processo para a preparacao de imidazotriazinonas substituidas por sulfonamida
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BRPI0413139A (pt) processo para a preparação de l-treonina
PT1432682E (pt) Processo para a preparacao de repaglinida
BR0213481A (pt) Sondas
BR0214742A (pt) Polimorfo cristalino de cloridrato de venlafaxina e métodos para sua preparação
BR9808642A (pt) Processo para preparar eprosartan
PT1292586E (pt) Processo para a preparacao de pirazolopirimidinonas
PT1363516E (pt) Um processo melhorado para a preparacao da sinvastatina
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
BR0214696A (pt) Monoidrato de cloridrato de venlafaxina e métodos para a preparação do mesmo
BRPI0411691A (pt) l-lisina de aztreonam e seus métodos de preparação

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired